India
· Delayed Price · Currency is INR Strides Pharma Science Statistics
Total Valuation
Strides Pharma Science has a market cap or net worth of INR 125.04 billion. The enterprise value is 146.70 billion.
| Market Cap | 125.04B |
| Enterprise Value | 146.70B |
Important Dates
The next estimated earnings date is Monday, October 28, 2024.
| Earnings Date | Oct 28, 2024 |
| Ex-Dividend Date | Sep 9, 2024 |
Share Statistics
Strides Pharma Science has 91.96 million shares outstanding. The number of shares has increased by 1.51% in one year.
| Shares Outstanding | 91.96M |
| Shares Change (YoY) | +1.51% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 7.88% |
| Owned by Institutions (%) | 31.43% |
| Float | 55.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 26.69 |
| PS Ratio | 2.95 |
| PB Ratio | 5.87 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2,189.24 |
| EV / Sales | 3.49 |
| EV / EBITDA | 22.36 |
| EV / EBIT | 34.17 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 121.49 |
| Debt / EBITDA | 3.10 |
| Debt / FCF | n/a |
| Interest Coverage | 1.83 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 7.46% |
| Revenue Per Employee | 14.77M |
| Profits Per Employee | 23,512 |
| Employee Count | 2,850 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +196.44% in the last 52 weeks. The beta is 0.82, so Strides Pharma Science's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +196.44% |
| 50-Day Moving Average | 1,110.55 |
| 200-Day Moving Average | 845.40 |
| Relative Strength Index (RSI) | 70.31 |
| Average Volume (20 Days) | 428,235 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Strides Pharma Science had revenue of INR 42.09 billion and earned 67.01 million in profits. Earnings per share was 0.73.
| Revenue | 42.09B |
| Gross Profit | 25.33B |
| Operating Income | 5.84B |
| Pretax Income | -320.90M |
| Net Income | 67.01M |
| EBITDA | 8.11B |
| EBIT | 5.84B |
| Earnings Per Share (EPS) | 0.73 |
Balance Sheet
The company has 2.97 billion in cash and 25.17 billion in debt, giving a net cash position of -22.20 billion or -241.41 per share.
| Cash & Cash Equivalents | 2.97B |
| Total Debt | 25.17B |
| Net Cash | -22.20B |
| Net Cash Per Share | -241.41 |
| Equity (Book Value) | 20.72B |
| Book Value Per Share | 231.56 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.18%, with operating and profit margins of 13.88% and 0.16%.
| Gross Margin | 60.18% |
| Operating Margin | 13.88% |
| Pretax Margin | -0.76% |
| Profit Margin | 0.16% |
| EBITDA Margin | 19.26% |
| EBIT Margin | 13.88% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.50, which amounts to a dividend yield of 0.18%.
| Dividend Per Share | 2.50 |
| Dividend Yield | 0.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.51% |
| Shareholder Yield | -1.33% |
| Earnings Yield | 0.05% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |